Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10
Review
Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
2,047 | Dovepress* | 1,680+ | 51 | 1,731 | |
PubMed Central* | 367 | 116 | 483 | ||
Totals | 2,047 | 167 | 2,214 | ||
*Since 27 October 2023 |
View citations on PubMed and Google Scholar